CVE-2021-4308: A vulnerability was found in WebPA up to 3.1.1
CVE-2021-4308 is a medium-severity flaw (CVSS 5.5) affecting webpa. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
A vulnerability was found in WebPA up to 3.1.1. It has been rated as critical. This issue affects some unknown processing. The manipulation leads to sql injection. Upgrading to version 3.1.2 is able to address this issue. The identifier of the patch is 8836c4f549181e885a68e0e7ca561fdbcbd04bf0. It is recommended to upgrade the affected component. The identifier VDB-217637 was assigned to this vulnerability.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.5 (Medium) |
| Attack vector | Adjacent network |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.7% (top 46%) |
| CISA exploited list | No |
| Weakness | CWE-89 |
| Published | 2023-01-08 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2021-4308?
webpa: upgrade to 3.1.2. Exact commands for each OS are on this page.
Is CVE-2021-4308 being exploited?
CVE-2021-4308 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2021-4308 affect?
CVE-2021-4308 affects webpa. Severity is medium (CVSS 5.5). A vulnerability was found in WebPA up to 3.1.1. It has been rated as critical. This issue affects some unknown processing. The manipulation leads to sql injection. Upgrading to version 3.1.2 is able to address this issue. The identifier of
How urgent is CVE-2021-4308?
Priority 33/100. No elevated risk signals yet.